Johnson & Johnson (JNJ)
NYSE
273.04
+2.80 (+1.04%)
Closed
Aug 24, 2026
Day's Range
268.57273.98
52 wk Range
173.33276.47
Financial Statements - JNJ - Johnson & Johnson
Revenue
94.19B▲ 6.0%
Net Income
26.80B▲ 90.6%Net Margin 28.5%
EBITDA
35.16B▲ 10.1%
Free Cash Flow
19.31B▲ 6.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 94.19B | 88.82B | 85.15B | 79.99B | 78.74B | 82.58B |
| Cost of Goods | 30.25B | 27.47B | 26.55B | 24.59B | 23.40B | 28.42B |
| Gross Profit | 63.93B | 61.35B | 58.60B | 55.39B | 55.33B | 54.15B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 25.59B | 21.24B | 23.40B | 22.21B | 20.94B | 19.73B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 6.89B | -5.14B | -8.80B | -3.05B | -1.63B | -3.14B |
| Pre Tax Income | 32.58B | 16.68B | 15.06B | 19.35B | 19.17B | 16.49B |
| Income Tax | 5.77B | 2.62B | 1.73B | 2.98B | 1.37B | 1.78B |
| Net Income | 26.80B | 14.06B | 35.15B | 17.94B | 20.87B | 14.71B |
| EPS Basic | 11.13 | 5.843978 | 13.88 | 6.862158 | 7.930572 | 5.589273 |
| EPS Diluted | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 | 5.51 |
| Basic Shares Outstanding | 2.40B | 2.40B | 2.53B | 2.61B | 2.62B | 2.63B |
| Diluted Shares Outstanding | 2.40B | 2.40B | 2.53B | 2.61B | 2.62B | 2.63B |
| Ebit | 33.55B | 17.44B | 15.83B | 19.63B | 19.36B | 16.69B |
| Ebitda | 35.16B | 31.92B | 32.32B | 30.16B | 27.86B | 24.17B |
| Net Income Continuous Operations | 26.80B | 14.06B | 35.15B | 17.94B | 20.87B | 14.71B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
